Twenty-two women who took part in recent trials for a gel designed to prevent HIV infection during intercourse have contracted the virus, South Africa's health ministry said on Wednesday.
Researchers have halted two studies of an anti-AIDS vaginal gel in Africa and India after early results suggested it might raise the risk of HIV infection instead of lowering it.
Treating genital herpes can also help keep the AIDS virus under control in women with both infections, and might reduce the spread of HIV as well, the first major study to test this strategy suggests.
A highly drug-resistant form of tuberculosis has killed about 85 percent of South African HIV patients who have become infected, presenting one of the most worrisome problems in HIV and tuberculosis control, researchers reported Sunday.
